170 related articles for article (PubMed ID: 15867955)
1. Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review.
Nicol AF; Fernandes AT; Bonecini-Almeida Mda G
Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):1-12. PubMed ID: 15867955
[TBL] [Abstract][Full Text] [Related]
2. Immune factors involved in the cervical immune response in the HIV/HPV co-infection.
Nicol AF; Nuovo GJ; Salomão-Estevez A; Grinsztejn B; Tristão A; Russomano F; Lapa E Silva JR; Oliveira MP; Pirmez C
J Clin Pathol; 2008 Jan; 61(1):84-8. PubMed ID: 17483251
[TBL] [Abstract][Full Text] [Related]
3. Origin and immunoescape of uterine cervical cancer.
Van Hede D; Langers I; Delvenne P; Jacobs N
Presse Med; 2014 Dec; 43(12 Pt 2):e413-21. PubMed ID: 25448124
[TBL] [Abstract][Full Text] [Related]
4. Anogenital papillomavirus infection and neoplasia in immunodeficient women.
Wright TC; Sun XW
Obstet Gynecol Clin North Am; 1996 Dec; 23(4):861-93. PubMed ID: 8989779
[TBL] [Abstract][Full Text] [Related]
5. Intra-epithelial and invasive cervical neoplasia during HIV infection.
Boccalon M; Tirelli U; Sopracordevole F; Vaccher E
Eur J Cancer; 1996 Dec; 32A(13):2212-7. PubMed ID: 9038602
[TBL] [Abstract][Full Text] [Related]
6. [The role of some micronutrients in the evolution of HPV infection].
Atlante M; Mariani L; Luci M; Carico E; Diotallevi F; Iacovelli A; Vincenzoni C
Minerva Ginecol; 2002 Apr; 54(2):179-83. PubMed ID: 12032456
[TBL] [Abstract][Full Text] [Related]
7. The Catastrophic HPV/HIV Dual Viral Oncogenomics in Concert with Dysregulated Alternative Splicing in Cervical Cancer.
Marima R; Hull R; Lolas G; Syrigos KN; Kgoebane-Maseko M; Kaufmann AM; Dlamini Z
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576278
[TBL] [Abstract][Full Text] [Related]
8. Lower genital tract neoplasia in women with HIV infection.
Abercrombie PD; Korn AP
Oncology (Williston Park); 1998 Dec; 12(12):1735-9; discussion 1742, 1745, 1747. PubMed ID: 9874847
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
[TBL] [Abstract][Full Text] [Related]
10. Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status.
Garzetti GG; Ciavattini A; Butini L; Vecchi A; Montroni M
Gynecol Obstet Invest; 1995; 40(1):52-6. PubMed ID: 7557645
[TBL] [Abstract][Full Text] [Related]
11. Genital dysplasia in women infected with human immunodeficiency virus.
Taylor G; Wolff T; Khanna N; Furth P; Langenberg P
J Am Board Fam Pract; 2004; 17(2):108-13. PubMed ID: 15082669
[TBL] [Abstract][Full Text] [Related]
12. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
Riva E; Serraino D; Pierangeli A; Bambacioni F; Zaniratti S; Minosse C; Selleri M; Bucci M; Scagnolari C; Degener AM; Capobianchi MR; Antonelli G; Dianzani F;
Clin Microbiol Infect; 2007 Jan; 13(1):94-7. PubMed ID: 17184295
[TBL] [Abstract][Full Text] [Related]
13. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer.
Clarke B; Chetty R
Mol Pathol; 2002 Feb; 55(1):19-24. PubMed ID: 11836442
[TBL] [Abstract][Full Text] [Related]
14. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras.
Ferrera A; Melchers WJ; Velema JP; Figueroa M
Am J Trop Med Hyg; 1997 Aug; 57(2):138-41. PubMed ID: 9288804
[TBL] [Abstract][Full Text] [Related]
15. Local impairment of immunoreactivity in HIV-infected women with HPV-related squamous intraepithelial lesions of the cervix.
Barberis MC; Vago L; Cecchini G; Bramerio M; Banfi G; D'Amico M; Cannone M
Tumori; 1998; 84(4):489-92. PubMed ID: 9825002
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of cervical abnormalities among HIV-infected African women.
Folkers G
NIAID AIDS Agenda; 1996 Jun; ():9, 11. PubMed ID: 11363811
[TBL] [Abstract][Full Text] [Related]
18. The prevention of cervical cancer in HIV-infected women.
Franceschi S; Ronco G
AIDS; 2010 Oct; 24(16):2579-80. PubMed ID: 20940536
[No Abstract] [Full Text] [Related]
19. Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia.
Braun L
Am J Pathol; 1994 Feb; 144(2):209-14. PubMed ID: 8311108
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions.
Lee BN; Follen M; Tortolero-Luna G; Eriksen N; Helfgott A; Hammill H; Shearer WT; Reuben JM
Gynecol Oncol; 1999 Dec; 75(3):379-86. PubMed ID: 10600293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
